BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.480,29 PKT -6,17 PKT -0,42 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
19.11.12 UBS halten Norddeutsche Landesbank (Nord/LB)
19.11.12 UBS buy Sarasin Research
19.11.12 Zurich Insurance halten Independent Research GmbH
16.11.12 Zurich Insurance neutral HSBC
16.11.12 Givaudan outperform Exane-BNP Paribas SA
16.11.12 Novartis outperform Exane-BNP Paribas SA
16.11.12 Zurich Insurance neutral J.P. Morgan Cazenove
16.11.12 Zurich Insurance neutral Exane-BNP Paribas SA
16.11.12 Zurich Insurance buy Nomura
16.11.12 Zurich Insurance buy Société Générale Group S.A. (SG)
16.11.12 ABB (Asea Brown Boveri) kaufen Hamburger Sparkasse AG (Haspa)
16.11.12 Zurich Insurance hold Vontobel Research
15.11.12 Swiss Re kaufen Hamburger Sparkasse AG (Haspa)
15.11.12 Novartis buy UBS AG
15.11.12 Logitech equal-weight Morgan Stanley
15.11.12 Zurich Insurance neutral Sarasin Research
15.11.12 Zurich Insurance hold Vontobel Research
15.11.12 ABB (Asea Brown Boveri) buy Vontobel Research
15.11.12 Novartis outperform Sanford C. Bernstein and Co., Inc.
14.11.12 Sonova neutral UBS AG
14.11.12 Sonova overweight J.P. Morgan Cazenove
14.11.12 Geberit halten Öko Invest
14.11.12 Sonova underperform Exane-BNP Paribas SA
14.11.12 Swiss Life buy Nomura
14.11.12 Nestlé overweight Morgan Stanley
14.11.12 Julius Bär buy Sarasin Research
14.11.12 Julius Bär reduce Vontobel Research
14.11.12 UBS overweight Morgan Stanley
14.11.12 Sonova buy Vontobel Research
13.11.12 Swiss Life buy Vontobel Research
13.11.12 Swisscom hold Vontobel Research
13.11.12 Sonova buy Vontobel Research
13.11.12 Swiss Life buy Sarasin Research
13.11.12 Sonova neutral Sarasin Research
12.11.12 Novartis outperform Credit Suisse Group
12.11.12 Holcim hold Deutsche Bank AG
12.11.12 Swisscom neutral Nomura
12.11.12 Richemont buy Nomura
12.11.12 Sonova underperform Exane-BNP Paribas SA
12.11.12 Richemont buy Vontobel Research